Ensuring timely launch: QbD Group's role in establishing a hemophilia drug production line

    Ensuring timely launch: QbD Group's role in establishing a hemophilia drug production line

    circles-1

    BioTech-icon

    Biotech company

    Tag_icon

    Qualification & Validation

    Medicine-icon

    Pharma

    share-iconshare-icon-mob Share

    X (Twitter) icon\ \ X (Twitter) LinkedIn icon\ \ LinkedIn WhatsApp icon\ \ WhatsApp Copy link icon\ \ Copy link Mail icon\ \ Mail

    New hemophilia drug line for large biotech

    QbD Group has facilitated the launch of a new drug production line for treating hemophilia, overseeing the qualification of over 100 pieces of small-scale supporting equipment.

    1

    Challenge

    Challenge

    2

    Approach

    Approach

    3

    result_icon

    Result

    Challenge

    Challenge

    Overcoming coordination & timeline challenges

    The project faced several challenges that required meticulous coordination and execution. The construction, procurement, validation, and production departments had to align their priorities with strict timelines to ensure the seamless launch of the new production line.

    Additionally, the client had limited resources for the final review and approval stages, making efficient and clear communication essential to avoid delays.

    Furthermore, over 100 pieces of small-scale equipment, divided into four work packages, needed thorough qualification within a tight timeline. This was crucial for supporting timely process validation runs and ensuring the production line was ready and compliant with regulatory standards.

    Approach

    Approach

    Risk-based approach & streamlined project management

    To address the challenges, a risk-based approach was used to create and execute the qualification documentation within the limited timeframe. This ensured that all critical aspects were prioritized and managed effectively.

    The team focused on quality-driven continuous improvement to establish a more robust framework for operations.

    Additionally, the QbD Group team took on overall project planning and follow-up, streamlining processes and enhancing efficiency throughout the project.

    Results

    Result

    Equipment qualification & continuous support

    The required equipment was qualified and implemented on schedule, allowing the production department to start process validation runs as planned.

    In addition, part of the project team continued to support the client even after the project’s official closure.

    Cleanroom-2-1-qqeb2f36ejtaiuls0rq68o45rdyofvgdsum8huj2jk

    Cleanroom-1-1-qqeb2f36ejtaiuls0rq68o45rdyofvgdsum8huj2jk

    13-4-qqeaynqf2eo0302dz57w9m9s7whtngj1a8obe03rfk

    contact-mail

    Get in touch

    Also need help with the roll out of your production line?

    Discover how our QMS experts can help you or contact us directly. We’d be happy to assist you!

    Get in touch_QbD group-1

    First name*

    Last name*

    Professional Email*

    Company name*

    Role*

    Please SelectC-level / VPDirector(Sr.) ManagerSpecialist/AnalystIntern/ApprenticeIndividual contributorOther

    Department*

    Please SelectStrategy & ManagementRegulatory & VigilanceQuality Assurance & ControlIT & Digital InnovationManufacturing & ProductionProduct DevelopmentResearch & InnovationClinical Affairs & OperationsMedical AffairsMarket AccessSales & MarketingHRProcurementOther

    Mobile phone number

    Country*

    Please SelectAfghanistanÅland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAsia/Pacific RegionAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCote d'IvoireCroatiaCubaCuraçaoCyprusCzech RepublicDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEast TimorEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaEuropeFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern and Antarctic LandsGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRéunionRomaniaRussiaRwandaSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

    Industry *

    Please SelectMedical DevicesIn Vitro DiagnosticsPharmaBiotechAnimal HealthService providerConsumer HealthOther

    Question submitted*

    Field of Interest at time of last SRA

    Content Title

    Content Type

    Content Division

    QbD Group is committed to protecting and respecting your privacy, and we’ll use your personal information to administer your account and to provide the products and services you requested from us.

    • Yes, I agree to receive personalized newsletters with market insights, invitations for exclusive events and educational webinars from the QbD Group.

    • I consent to the privacy policy and understand that my personal data will be stored and processed *